|
Index of reports
> Hospitalization (27)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prohance (Gadoteridol) hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Prohance side effects in 84 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23
Patient: 84 year old female, weighing 66.0 kg (145.2 pounds)
Reactions: Anaphylactic Shock
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2012-02-23
End date: 2012-02-23
Prohance
Indication: Lung Neoplasm Malignant
Start date: 2012-02-23
End date: 2012-02-23
Possible Prohance side effects in male
Reported by a physician from Germany on 2012-07-05
Patient: male
Reactions: Contusion, Circulatory Collapse, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Possible Prohance side effects in 62 year old female
Reported by a physician from Germany on 2012-05-08
Patient: 62 year old female
Reactions: Dyspnoea, Circulatory Collapse
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prohance
Possible Prohance side effects in 72 year old male
Reported by a physician from Japan on 2012-04-18
Patient: 72 year old male
Reactions: Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2012-04-09
End date: 2012-04-09
Prohance
Indication: Metastases To Central Nervous System
Start date: 2012-04-09
End date: 2012-04-09
Other drugs received by patient: Chemotherapeutics
Possible Prohance side effects in 84 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-06
Patient: 84 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Nausea, Dizziness, Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2012-02-14
End date: 2012-02-14
Prohance
Indication: Ovarian Neoplasm
Start date: 2012-02-14
End date: 2012-02-14
Possible Prohance side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-09
Patient: female
Reactions: Back Pain, Lacrimation Increased, Erythema, Eye Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Possible Prohance side effects in male
Reported by a physician from Germany on 2012-03-09
Patient: male
Reactions: Contusion, Circulatory Collapse, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Possible Prohance side effects in 84 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-02
Patient: 84 year old female
Reactions: Blood Pressure Decreased, Oxygen Saturation Decreased, Loss of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Possible Prohance side effects in 63 year old male
Reported by a physician from Japan on 2012-03-01
Patient: 63 year old male, weighing 76.0 kg (167.2 pounds)
Reactions: Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Brain Cancer Metastatic
Start date: 2012-02-07
End date: 2012-02-07
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2012-02-07
End date: 2012-02-07
Other drugs received by patient: Norvasc; Halcion; Losartan Potassium and Hydrochlorothiazide
Possible Prohance side effects in female
Reported by a physician from United States on 2012-02-27
Patient: female, weighing 82.4 kg (181.3 pounds)
Reactions: Electrocardiogram ST Segment Depression, Periorbital Cellulitis, Hypertensive Emergency, Electrocardiogram QT Shortened, Angina Unstable, Vascular Graft Thrombosis, Haematemesis, Off Label Use, Ileus, Electrocardiogram T Wave Abnormal, Arteriovenous Fistula Site Complication, Dysphagia, Nausea, Nephrogenic Systemic Fibrosis, Hyperlipidaemia, Renal Failure, Diarrhoea, QRS Axis Abnormal
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Optimark
Dosage: 20 ml, single
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-03-24
End date: 2005-03-24
Prohance
Dosage: 17 ml, single
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-04-27
End date: 2004-04-27
Other drugs received by patient: Norvasc; Synthroid; Zemplar; Atacand; Nephrocaps; Epogen; Renagel; Ferrlecit / 00345601 /; Insulin; Catapres / 00171101 /
Possible Prohance side effects in 84 year old female
Reported by a physician from Japan on 2012-02-23
Patient: 84 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Nausea, Dizziness, Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Possible Prohance side effects in 63 year old male
Reported by a physician from Japan on 2012-02-14
Patient: 63 year old male, weighing 76.0 kg (167.2 pounds)
Reactions: Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Brain Cancer Metastatic
Start date: 2012-02-07
End date: 2012-02-07
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2012-02-07
End date: 2012-02-07
Other drugs received by patient: Losartan Potassium and Hydrochlorothiazide; Halcion; Norvasc
Possible Prohance side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-13
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Vision Blurred, Diastolic Dysfunction, Anaphylactic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Osteomyelitis
Start date: 2011-12-19
End date: 2011-12-19
Prohance
Indication: Infection
Start date: 2011-12-19
End date: 2011-12-19
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2011-12-19
End date: 2011-12-19
Other drugs received by patient: Levothyroxine Sodium; Savella; Fluoxetine; Calcium; Acetaminop. W / Butalbital / Caff. / Codeine Phosp.; Spironolactone; Vitamin D; Advair Diskus 100 / 50; Bumex
Possible Prohance side effects in 60 year old female
Reported by a physician from Japan on 2012-02-02
Patient: 60 year old female, weighing 69.0 kg (151.8 pounds)
Reactions: Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2012-01-11
End date: 2012-01-11
Prohance
Indication: Breast Cancer
Start date: 2012-01-11
End date: 2012-01-11
Possible Prohance side effects in 36 year old female
Reported by a physician from Japan on 2012-01-30
Patient: 36 year old female
Reactions: Anaphylactic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Breast Cancer
Start date: 2012-01-13
End date: 2012-01-13
Prohance
Indication: Diagnostic Procedure
Start date: 2012-01-13
End date: 2012-01-13
Possible Prohance side effects in 67 year old female
Reported by a physician from Japan on 2012-01-24
Patient: 67 year old female
Reactions: Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Neoplasm Malignant
Start date: 2011-12-26
End date: 2011-12-26
Prohance
Indication: Diagnostic Procedure
Start date: 2011-12-26
End date: 2011-12-26
Possible Prohance side effects in 36 year old female
Reported by a physician from Japan on 2012-01-19
Patient: 36 year old female
Reactions: Abdominal Pain, Generalised Oedema, Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Possible Prohance side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-13
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Anaphylactic Shock, Diastolic Dysfunction, Vision Blurred
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Osteomyelitis
Start date: 2011-12-19
End date: 2011-12-19
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2011-12-19
End date: 2011-12-19
Prohance
Indication: Infection
Start date: 2011-12-19
End date: 2011-12-19
Other drugs received by patient: Acetaminop. W / Butalbital / Caff. / Codeine Phosp.; Calcium; Fluoxetine; Savella; Bumex; Advair Diskus 100 / 50; Vitamin D; Spironolactone; Levothyroxine Sodium
Possible Prohance side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-05
Patient: 62 year old female
Reactions: Anaphylactic Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Dosage: 15ml once intravenous (not otherwise specified)
Indication: Mass
Start date: 2011-05-03
End date: 2011-05-03
Prohance
Dosage: 15ml once intravenous (not otherwise specified)
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2011-05-03
End date: 2011-05-03
Other drugs received by patient: Norvasc; Vasotec
Possible Prohance side effects in 53 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-05
Patient: 53 year old female
Reactions: Flushing, Pharyngeal Oedema, Chest Discomfort, Dyspnoea, Throat Irritation, Sneezing, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Other drugs received by patient: Levoxyl; Naprosyn
Possible Prohance side effects in 74 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-05
Patient: 74 year old female, weighing 73.0 kg (160.6 pounds)
Reactions: Syncope, Unresponsive To Stimuli, Feeling Hot
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Dosage: 15ml once intravenous (not otherwise specified)
Indication: Asthenia
Start date: 2011-08-29
End date: 2011-08-29
Prohance
Dosage: 15ml once intravenous (not otherwise specified)
Indication: Multiple Sclerosis
Start date: 2011-08-29
End date: 2011-08-29
Prohance
Dosage: 15ml once intravenous (not otherwise specified)
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2011-08-29
End date: 2011-08-29
Prohance
Dosage: 15ml once intravenous (not otherwise specified)
Indication: Gait Disturbance
Start date: 2011-08-29
End date: 2011-08-29
Possible Prohance side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-28
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Anaphylactic Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Infection
Start date: 2011-12-19
End date: 2011-12-19
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2011-12-19
End date: 2011-12-19
Prohance
Indication: Osteomyelitis
Start date: 2011-12-19
End date: 2011-12-19
Other drugs received by patient: Spironolactone; Acetaminop. W / Butalbital / Caff. / Codeine Phosp.; Savella; Fluoxetine; Vitamin D; Levothyroxine Sodium; Bumex; Advair Diskus 100 / 50; Calcium Acetate
Possible Prohance side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-21
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Respiratory Arrest, Sneezing
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Infection
Start date: 2011-12-19
End date: 2011-12-19
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2011-12-19
End date: 2011-12-19
Possible Prohance side effects in 72 year old male
Reported by a consumer/non-health professional from United States on 2011-11-21
Patient: 72 year old male, weighing 97.5 kg (214.5 pounds)
Reactions: Restlessness, Urinary Incontinence, Dyskinesia, Toxicity To Various Agents, Tremor, NO Therapeutic Response, DRY Throat, Contrast Media Allergy, Hallucination, Asthenia, Nervousness, Muscle Spasms
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Prohance
Possible Prohance side effects in 82 year old male
Reported by a physician from Japan on 2011-11-15
Patient: 82 year old male
Reactions: Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2011-10-19
End date: 2011-10-19
Prohance
Indication: Metastases To Bone
Start date: 2011-10-19
End date: 2011-10-19
Possible Prohance side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-11-08
Patient: 57 year old male
Reactions: Renal Transplant, Nephrogenic Systemic Fibrosis, Immobile
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Prohance
Dosage: 15 ml, single dose, 15 ml, single, 15 ml, single dose, 15 ml, single dose,
Start date: 2006-07-18
End date: 2006-08-17
Prohance
Dosage: 15 ml, single dose, 15 ml, single, 15 ml, single dose, 15 ml, single dose,
Start date: 2006-09-20
End date: 2006-09-20
Prohance
Dosage: 15 ml, single dose, 15 ml, single, 15 ml, single dose, 15 ml, single dose,
Start date: 2007-01-10
End date: 2007-01-10
Prohance
Dosage: 15 ml, single dose, 15 ml, single, 15 ml, single dose, 15 ml, single dose,
Start date: 2007-05-01
End date: 2007-05-01
Omniscan
Dosage: 15 ml, single dose, intravenous;15 ml, single dose, intravenous; 15 ml, single dose, intravenous
Indication: Central Nervous System Abscess
Start date: 2006-05-13
End date: 2006-05-13
Omniscan
Dosage: 15 ml, single dose, intravenous;15 ml, single dose, intravenous; 15 ml, single dose, intravenous
Indication: Central Nervous System Abscess
Start date: 2006-08-23
End date: 2006-08-23
Omniscan
Dosage: 15 ml, single dose, intravenous;15 ml, single dose, intravenous; 15 ml, single dose, intravenous
Indication: Central Nervous System Abscess
Start date: 2006-08-31
End date: 2006-08-31
Possible Prohance side effects in 38 year old female
Reported by a physician from Japan on 2011-11-03
Patient: 38 year old female
Reactions: Tetany
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prohance
|
